Platinum Bio Fully Adopts RNA-seq Analysis Cloud Platform "Basepair"
Platinum Bio announced the full adoption of Basepair, an RNA-seq analysis cloud platform, to begin service on May 1, 2026. This platform enables companies without bioinformatics specialists to easily perform in-depth RNA-seq data analysis through an interactive browser-based environment.
📋 Article Processing Timeline
- 📰 Published: May 7, 2026 at 19:00
- 🔍 Collected: May 7, 2026 at 10:31
- 🤖 AI Analyzed: May 7, 2026 at 10:35 (3 min after Collected)
Platinum Bio Co., Ltd. (Headquarters: Higashihiroshima City, Hiroshima Prefecture, Representative Director and CEO: Keisuke Okuhara, hereinafter "Platinum Bio") and Iwai Chemicals Company, Limited (Headquarters: Chuo-ku, Tokyo, Representative Director: Yoshiko Iwai, hereinafter "Iwai Chemicals") announce that Platinum Bio has fully adopted "Basepair," an RNA-seq analysis cloud platform provided by Basepair Inc. (USA), and will begin applying it to its RNA-seq data analysis services from May 1, 2026. Iwai Chemicals, as Basepair's domestic sales partner, will support the introduction and operation of this platform for Platinum Bio.
This service combines Platinum Bio's strength in RNA-seq analysis expertise with Basepair's browser-based interactive visualization environment, offering a new data analysis service that allows customers without bioinformatics specialists within their companies to explore and confirm analysis results with their own hands.
**■ Background of Introduction**
RNA-seq (RNA sequencing) is a technology widely used from basic research to industrial applications for comprehensively analyzing gene expression levels. However, extracting meaningful biological insights from large amounts of sequence data requires multi-stage bioinformatics processes such as data processing, quality control, statistical analysis, and visualization. For service providers, the workload of specialized personnel becomes a bottleneck for delivery time and cost. For customers requesting analysis, simply waiting to receive a delivered report makes it difficult to exploratively confirm critical insights for their own hypotheses from the vast amount of data. This presents a structural challenge, especially for R&D departments and companies that do not have bioinformatics personnel in-house, making it difficult to flexibly respond to requests such as re-analyzing with different thresholds or sharing results with collaborators, thus hindering the effective utilization of analysis results.
Platinum Bio boasts a track record of providing RNA-seq analysis services specialized in non-model organisms and industrially useful organisms, along with value-added analysis (RNA-seq meta-analysis) through proprietary curation of public databases. With the full adoption of the Basepair platform, Platinum Bio will streamline standard RNA-seq analysis processes and provide an environment where customers themselves can interactively explore and re-analyze results instantly on a browser using Basepair's visualization functions. This enables:
**For Customers:** To actively explore analysis results from their personal computers without requiring specialized programming knowledge or high-performance analysis machines, and easily change thresholds, re-analyze, and share results with collaborators.
**For Platinum Bio:** To establish a system that allows resources to be concentrated on continuous support where the company can exert the most value: biological interpretation of analysis results and proposing next actions.
The goal is to enhance the quality and speed of collaboration between both parties and shorten the lead time to research and development decision-making.
**■ Results of Trial Evaluation**
Platinum Bio conducted a trial evaluation of Basepair from September to December 2025, with the cooperation of researchers inside and outside the company. All predetermined key achievement goals were met, leading to the decision for full-scale introduction (detailed figures are not disclosed).
**Main Evaluations from Participants**
Participants highly praised Basepair for both its usability and practical applicability. In particular, participants without bioinformatics specialists in-house positively received the ability to confirm and utilize results with their own hands.
**Participant Comments (Excerpts)**
"Being able to experience analysis from fastq to PCA-plot and volcano-plot with one click felt truly innovative."
"The ability to easily perform analysis from any computer without needing a high-performance machine is a significant advantage."
"Analysis that would be quite troublesome if writing scripts felt quick and easy to execute."
"Being able to change parameters on the browser and confirm results on the spot speeds up discussions."
Furthermore, interactive visualization functions, applicability to practical work, ease of data sharing, abundant visualization options, and processing speed were highly evaluated.
**Expected Efficiencies**
Participants expressed expectations that applying Basepair to real data would significantly shorten the time required for data confirmation and report interpretation, and that the lead time to decision-making based on experimental results would be reduced by approximately half.
(*The above are the results of a trial evaluation conducted by Platinum Bio; effects may vary depending on the analysis target and data scale.)
**■ Service Provision System**
Service
This service combines Platinum Bio's strength in RNA-seq analysis expertise with Basepair's browser-based interactive visualization environment, offering a new data analysis service that allows customers without bioinformatics specialists within their companies to explore and confirm analysis results with their own hands.
**■ Background of Introduction**
RNA-seq (RNA sequencing) is a technology widely used from basic research to industrial applications for comprehensively analyzing gene expression levels. However, extracting meaningful biological insights from large amounts of sequence data requires multi-stage bioinformatics processes such as data processing, quality control, statistical analysis, and visualization. For service providers, the workload of specialized personnel becomes a bottleneck for delivery time and cost. For customers requesting analysis, simply waiting to receive a delivered report makes it difficult to exploratively confirm critical insights for their own hypotheses from the vast amount of data. This presents a structural challenge, especially for R&D departments and companies that do not have bioinformatics personnel in-house, making it difficult to flexibly respond to requests such as re-analyzing with different thresholds or sharing results with collaborators, thus hindering the effective utilization of analysis results.
Platinum Bio boasts a track record of providing RNA-seq analysis services specialized in non-model organisms and industrially useful organisms, along with value-added analysis (RNA-seq meta-analysis) through proprietary curation of public databases. With the full adoption of the Basepair platform, Platinum Bio will streamline standard RNA-seq analysis processes and provide an environment where customers themselves can interactively explore and re-analyze results instantly on a browser using Basepair's visualization functions. This enables:
**For Customers:** To actively explore analysis results from their personal computers without requiring specialized programming knowledge or high-performance analysis machines, and easily change thresholds, re-analyze, and share results with collaborators.
**For Platinum Bio:** To establish a system that allows resources to be concentrated on continuous support where the company can exert the most value: biological interpretation of analysis results and proposing next actions.
The goal is to enhance the quality and speed of collaboration between both parties and shorten the lead time to research and development decision-making.
**■ Results of Trial Evaluation**
Platinum Bio conducted a trial evaluation of Basepair from September to December 2025, with the cooperation of researchers inside and outside the company. All predetermined key achievement goals were met, leading to the decision for full-scale introduction (detailed figures are not disclosed).
**Main Evaluations from Participants**
Participants highly praised Basepair for both its usability and practical applicability. In particular, participants without bioinformatics specialists in-house positively received the ability to confirm and utilize results with their own hands.
**Participant Comments (Excerpts)**
"Being able to experience analysis from fastq to PCA-plot and volcano-plot with one click felt truly innovative."
"The ability to easily perform analysis from any computer without needing a high-performance machine is a significant advantage."
"Analysis that would be quite troublesome if writing scripts felt quick and easy to execute."
"Being able to change parameters on the browser and confirm results on the spot speeds up discussions."
Furthermore, interactive visualization functions, applicability to practical work, ease of data sharing, abundant visualization options, and processing speed were highly evaluated.
**Expected Efficiencies**
Participants expressed expectations that applying Basepair to real data would significantly shorten the time required for data confirmation and report interpretation, and that the lead time to decision-making based on experimental results would be reduced by approximately half.
(*The above are the results of a trial evaluation conducted by Platinum Bio; effects may vary depending on the analysis target and data scale.)
**■ Service Provision System**
Service